Static Chart Hanall Biopharma Co., Ltd.

Equities

End-of-day quote Korea S.E. Other stock markets 03:30:00 24/06/2024 am IST			5-day change	1st Jan Change
32,300 ^KRW	-3.15%		-4.30%	-27.09%

14/05	Hanall Biopharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03/05	HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease	CI

Duration

Period